IRCT20140107016123N14 IRCT 2019-12-04 Ahvaz University of Medical Sciences The effect of pomegranate extract on non alcoholic fatty liver The effect of pomegranate extract tablet on some of metabolic factor, hepatokines (fetuin A, FGF21), inflammatory biomarkers, anthropometric indices and grade of fatty liver in patients with non-alcoholic fatty Liver disease 2019-11-22 anticipated 50 Complete https://irct.ir/trial/42739 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: The present study is a simple randomized clinical trial on subjects with nonalcholic fatty liver. In this study, individuals are divided into two groups of drugs and placebo.Randomization will done using quadratic block. Statistical software (Minitab) will use to perform randomized block, Blinding description: To make this study double-blinded and keep the researchers and participants unaware of the taken tablets, before the intervention, the container of pomegranate extract and placebo were coded as A or B by a third person (non-researcher). N/A Nonalcoholic fatty liver disease (NAFLD). Intervention 1: Intervention group: Pomegranate extract tablet 225 mg twice daily for 12 weeks. Intervention 2: Control group: Placebo twice daily for 12 weeks. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is It is not yet known if there will be a plan to make this available